Stock listing
Frankfurt:2CL BridgeBio Pharma, Inc. Aktie
German listing (Frankfurt) of BridgeBio Pharma, Inc. · home listing NASDAQ:BBIO
Follow BridgeBio Pharma, Inc. into a list and get an email when it puts out news.
Share price · FWB:2CL
€65.62 EUR +4.70 (+7.7%)
Close on Oct 30, 2026
- Day range
- €62.06 – €65.62 EUROct 30, 2026
- Market cap
- €12.83B EURAt the close on Oct 30, 2026 · price × 195.5M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BBIO · Home | $74.95 USD | +4.22 (+6.0%) | 5,770,977 | $72.85 | $75.65 | $71.91 | $70.73 | Close on Oct 30, 2026 |
| Frankfurt:2CL | €65.62 EUR | +4.70 (+7.7%) | — | €62.06 | €65.62 | €62.06 | €60.92 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:2CL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
Latest earnings call · Oct 29, 2026
Bridgebio Pharma (NASDAQ:BBIO) Q3 2026 Earnings Call
Replay and transcript
Latest deck · May 7, 2026
Q1 2026 Earnings Presentation
Earnings · 41 slides
Calls
Replays
Bridgebio Pharma (NASDAQ:BBIO) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 4:30 PM ET
Watch TranscriptBridgebio Pharma (NASDAQ:BBIO) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 4:30 PM ET
Watch TranscriptBridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call
Thu, May 07, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Financings
Preferred equity
Aug 10, 2026
Closed: US$1B raised
Buyers: Sixth Street (led the financing); HealthCare Royalty
Use of proceeds: Fund three potential upcoming launches while continuing to invest in indication expansion across the pipeline
Decks
Q1 2026 Earnings Presentation
Earnings · 41 slides · May 7, 2026
Investor Presentation (February 2026)
Investor deck · 92 slides · Feb 24, 2026
Q4 2025 Earnings Presentation
Earnings · 93 slides · Feb 24, 2026
Technical Presentation (February 2026)
Technical · 32 slides · Feb 12, 2026
BridgeBio Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 54 in the last 12 months · 269 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 7 calls with a replay · 7 with a transcript · latest Oct 29, 2026
- Decks
- 29 decks · latest May 7, 2026
Where BridgeBio Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BBIO · Home listing | NASDAQ | United States | USD |
| gettex:2CL | gettex | Germany | EUR |
| LS Exchange:A2PLX7 | LS Exchange | Germany | EUR |
| Tradegate:2CL | Tradegate | Germany | EUR |
| Lang & Schwarz:A2PLX7 | Lang & Schwarz | Germany | EUR |
| BX Swiss:BBIO | BX Swiss | Switzerland | CHF |
| Milan:1BBIO | Milan | Italy | EUR |
| BOATS:BBIO | BOATS | United States | USD |
| Frankfurt:2CL · This page | Frankfurt | Germany | EUR |
| Dusseldorf:2CL | Dusseldorf | Germany | EUR |
| Hamburg:2CL | Hamburg | Germany | EUR |
| Munich:2CL | Munich | Germany | EUR |
| Stuttgart:2CL | Stuttgart | Germany | EUR |
| BMV:BBIO | BMV | Mexico | MXN |
| Hanover:2CL | Hanover | Germany | EUR |
| Xetra:2CL | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about BridgeBio Pharma, Inc.